Guaifenesin And Pseudoephedrine Hcl 58602-0833-12
- Manufacturer
- Aurohealth Llc
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- March 25, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA213203
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 600 mg/1 |
| Pseudoephedrine Hydrochloride | 60 mg/1 |
Drug Class
Expectorant [EPC]Adrenergic alpha-Agonists [MoA]Decreased Respiratory Secretion Viscosity [PE]
Selected Package
58602-0833-12Selected1 BLISTER PACK in 1 CARTON (58602-833-12) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Other packages for this product(1)
2 BLISTER PACK in 1 CARTON (58602-833-17) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACK